DelveInsight has launched a new report on “Muscle Spasticity – Market Insights, Epidemiology, and Market Forecast-2030”.
DelveInsight’s “Muscle Spasticity – Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Muscle Spasticity, historical and forecasted epidemiology as well as the Muscle Spasticity market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Muscle Spasticity Market Report:
According to Pal (2014), Spasticity occurs at a variable rate among patients with multiple sclerosis (78%), stroke (35%), traumatic brain injury (50%), cerebral palsy (90%), and spinal cord injury (40%). Therapies for spasticity include medications, rehabilitation, local injections, surgery, and occupational and physical therapy programs
According to a study by Gill et al. (2020), Spasticity was present in 22% of residents examined by the neurologist. Only 11% of residents (5/45) had a prior diagnosis of spasticity and were receiving treatment. The presence of spasticity was associated with greater ADL dependency which was driven by lower limb spasticity. These results suggest that spasticity is common in nursing homes, is often not diagnosed or adequately treated, and is associated with worse ADL dependency.
Key benefits of the report:
Muscle Spasticity market report covers a descriptive overview and comprehensive insight of the Muscle Spasticity Epidemiology and Muscle Spasticity market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
The Muscle Spasticity market report provides insights on the current and emerging therapies.
Muscle Spasticity market report provides a global historical and forecasted market covering drug outreach in 7MM.
The Muscle Spasticity market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Muscle Spasticity market.
Muscle Spasticity Overview
Spasticity is defined as “sensorimotor disorder characterized by a velocity-dependent increase in tonic stretch reflexes with exaggerated tendon jerks, resulting from hyperexcitability of the stretch reflex” or from an upper motor neuron lesion (UMN), presenting as intermittent or sustained involuntary activation of muscles. The region and the extent of impairment depending on the area of the brain or spinal cord that has been damaged. It can occur in the upper and/or lower limbs.
Muscle Spasticity Market
The dynamics of the Muscle Spasticity market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as GW Pharmaceuticals, Revance Therapeutics, Ipsen, and others during the forecasted period 2018-2030.
Learn more by requesting for sample @ Muscle Spasticity Market Landscape
Muscle Spasticity Pipeline Therapies and Key Companies
Nabiximols: GW Pharmaceuticals
DAXI: Revance Therapeutics
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Muscle Spasticity Patient Share (%) Overview at a Glance
5. Muscle Spasticity Market Overview at a Glance
6. Muscle Spasticity Disease Background and Overview
7. Muscle Spasticity Epidemiology and Patient Population
8. Country-Specific Patient Population of Muscle Spasticity
9. Muscle Spasticity Current Treatment and Medical Practices
10. Unmet Needs
11. Muscle Spasticity Emerging Therapies
12. Muscle Spasticity Market Outlook
13. Country-Wise Muscle Spasticity Market Analysis (2018–2030)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
18. Muscle Spasticity Report Methodology
19. DelveInsight Capabilities
21. About DelveInsight
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States